Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics (DMAC) Other Working Capital Changes (2018 - 2026)

DiaMedica Therapeutics filings provide 9 years of Other Working Capital Changes readings, the most recent being $250000.0 for Q1 2026.

  • Quarterly Other Working Capital Changes fell 40.76% to $250000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $655000.0 through Mar 2026, up 478.61% year-over-year, with the annual reading at $15000.0 for FY2025, 96.2% down from the prior year.
  • Other Working Capital Changes hit $250000.0 in Q1 2026 for DiaMedica Therapeutics, up from $36000.0 in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $455000.0 in Q3 2024 and bottomed at -$700000.0 in Q4 2023.
  • Average Other Working Capital Changes over 5 years is $63898.5, with a median of $46250.0 recorded in 2023.
  • The largest annual shift saw Other Working Capital Changes plummeted 1233.33% in 2022 before it surged 2290.0% in 2024.
  • DiaMedica Therapeutics' Other Working Capital Changes stood at -$80000.0 in 2022, then plummeted by 775.0% to -$700000.0 in 2023, then soared by 92.43% to -$53000.0 in 2024, then skyrocketed by 167.92% to $36000.0 in 2025, then surged by 594.44% to $250000.0 in 2026.
  • Per Business Quant, the three most recent readings for DMAC's Other Working Capital Changes are $250000.0 (Q1 2026), $36000.0 (Q4 2025), and $45000.0 (Q3 2025).